Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PPH vs. FHLC: which is better?

Bottom line

PPH vs FHLC: the short answer

PPH (VanEck Pharmaceutical ETF) and FHLC (Fidelity MSCI Health Care Index ETF) share a meaningful slice of their top holdings — about 42% by weight.

But FHLC is far broader, holding 337 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.

FHLC is cheaper at 0.084% vs 0.36% — a difference of $28 a year per $10,000 invested.

Over five years, PPH returned +11.3% a year vs +7.2% for FHLC (reporting dates differ).

Updated Nov 19, 2026

PPH vs FHLC side by side

PPHFHLC
TypeETFETF
Fund familyVanEckFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.36%0.084%
Annual cost per $10k$36$8.4
10-yr cost on $10k (prospectus)$456$108
Max front loadNoneNone
12b-1 fee—0%
1-yr return+21.9%+2.6%
5-yr return (annualized)+11.3%+7.2%
10-yr return (annualized)+6.7%+8.8%
Best quarter+16.5%+16.4%
Worst quarter−15.0%−13.1%
Net assets (fund)$879.5M$3.3B
Number of holdings26337
Portfolio turnover3%3%
Returns as ofDec 31, 2025Nov 30, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPPHFHLCDifference
2024+8.1%+2.6%+5.5%
2023+6.9%+2.5%+4.4%
2022+2.6%−5.5%+8.1%
2021+18.3%+20.4%−2.1%
2020+5.2%+18.1%−12.9%
2019+19.1%+21.9%−2.8%
2018−5.7%+5.5%−11.2%
2017+15.4%+23.3%−7.9%
2016−17.8%−3.3%−14.4%

Source: Fund prospectus bar charts

Holdings overlap

8 of PPH's top 25 holdings also appear in FHLC's top 25.

Shared top holdings
HoldingPPHFHLC
Eli Lilly & Co20.23%13.35%
Merck & Co Inc9.85%4.66%
AbbVie Inc4.57%6.42%
Pfizer Inc4.51%2.06%
Bristol-Myers Squibb Co4.47%1.93%
Johnson & Johnson4.35%8.93%
McKesson Corp4.12%1.52%
Cencora Inc3.36%0.83%

Source: SEC Form N-PORT

PPH top 10

  1. Eli Lilly & Co — 20.23%
  2. Novartis AG — 10.63%
  3. Merck & Co Inc — 9.85%
  4. Novo Nordisk A/S — 5.37%
  5. AbbVie Inc — 4.57%
  6. Pfizer Inc — 4.51%
  7. Bristol-Myers Squibb Co — 4.47%
  8. Gsk Plc — 4.42%
  9. Johnson & Johnson — 4.35%
  10. AstraZeneca PLC — 4.33%

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

FAQ

What is the difference between PPH and FHLC?
PPH (VanEck Pharmaceutical ETF) and FHLC (Fidelity MSCI Health Care Index ETF) share a meaningful slice of their top holdings — about 42% by weight. But FHLC is far broader, holding 337 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.
Which is cheaper, PPH or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both PPH and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.